# Triple-negative Breast Cancer: a New Perspective on Biomarkers

> **NCT03539965** · — · COMPLETED · sponsor: **Instituto Nacional de Cancer, Brazil** · enrollment: 239 (actual)

## Conditions studied

- Triple Negative Breast Neoplasms
- Triple Negative Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03539965
- **Lead sponsor:** Instituto Nacional de Cancer, Brazil
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01-01
- **Primary completion:** 2014-12-31
- **Final completion:** 2014-12-31
- **Target enrollment:** 239 (ACTUAL)
- **Last updated:** 2018-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03539965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03539965, "Triple-negative Breast Cancer: a New Perspective on Biomarkers". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03539965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
